In conclusion, we demonstrated that SDF-1-positive CAFs were significant in malignant progression and gemcitabine resistance, partially owing to paracrine induction of SATB-1 in pancreatic cancer cells. The gene discussed is CXCL12; the disease is familial pancreatic carcinoma.